Last updated 16 days ago

Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

730 patients around the world
Available in Chile, United States, Spain
Merck Sharp & Dohme Corp.
7Research sites
730Patients around the world
This study is for people with
Solid tumors
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
Manzano 343, Recoleta, Región Metropolitana, Santiago
Clínica Puerto Montt
Recruiting
Calle Panamericana Nte. 400, Puerto Montt, Los Lagos
Oncovida - Santiago
Recruiting
Gral. Holley 2381, Providencia, Región Metropolitana, Santiago
James Lind Centro de Investigación del Cáncer - Temuco
Recruiting
Hochstetter 298, Temuco
Hospital Universitario Central de Asturias
Recruiting
Oviedo, 33011
Hospital General Universitario Gregorio Marañón
Recruiting
C. del Dr. Esquerdo, 46, 28007 Madrid
Hospital Vall de Hebrón
Recruiting
Pg. de la Vall d'Hebron, 119, 129, 08035 Barcelona, Spain
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy